2-Iodopyridin-3-yl acetate
Abstract
1. Introduction
2. Results and Discussion
2.1. Structural Description
2.2. X-Ray Diffraction Analysis
2.3. Hirshfeld Analysis
3. Materials and Methods
4. Conclusions
Supplementary Materials
Author Contributions
Funding
Data Availability Statement
Conflicts of Interest
References
- Marinescu, M.; Popa, C.-V. Pyridine Compounds with antimicrobial and antiviral activities. Int. J. Mol. Sci. 2022, 23, 5659. [Google Scholar] [CrossRef] [PubMed]
- Ravindar, L.; Hasbullah, S.A.; Rakesh, K.P.; Raheem, S.; Ismail, N.; Ling, L.Y.; Hassan, N.I. Pyridine and pyrimidine hybrids as privileged scaffolds in antimalarial drug discovery: A recent development. Bioorg. Med. Chem. Lett. 2024, 114, 129992. [Google Scholar] [CrossRef]
- De, S.; Kumar, A.K.S.K.; Shah, S.K.; Kazi, S.; Sarkar, N.; Banerjee, S.; Dey, S. Pyridine: The scaffolds with significant clinical diversity. RSC Adv. 2022, 12, 15385–15406. [Google Scholar] [CrossRef]
- Katoh, A.; Hashimoto, T. Molecular biology of pyridine nucleotide and nicotine biosynthesis. Front. Biosci. 2004, 9, 1577–1586. [Google Scholar] [CrossRef]
- Aishwaraya, N.V.S.S.; Matada, G.S.P.; Pal, R.; Aayishamma, I.; Housamani, K.R.; Kumaraswamy, B.; Majunshree, B.V.; Ghara, A. Expanding the potential of pyridine scaffold for targeted therapy of cancer: Biological activity, molecular insights, and structure-activity relationship. J. Mol. Struct. 2025, 1321, 139655. [Google Scholar] [CrossRef]
- Wang, S.; Yuan, X.-H.; Wang, S.-Q.; Zhao, W.; Chen, X.-B.; Yu, B. FDA-approved pyrimidine-fused bicyclic heterocycles for cancer therapy: Synthesis and clinical application. Eur. J. Med. Chem. 2021, 214, 113218. [Google Scholar] [CrossRef]
- Dwivedi, A.R.; Jaiswal, S.; Kukkar, D.; Kumar, R.; Singh, T.G.; Singh, M.P.; Gaidhane, A.M.; Lakhanpal, S.; Prasad, K.N.; Kumar, B. A decade of pyridine-containing heterocycles in US FDA approved drugs: A medicinal chemistry-based analysis. RSC Med. Chem. 2025, 16, 12–36. [Google Scholar] [CrossRef]
- Davis, E.A.; Hammet, M.S.; Scheerer, J.R. Halogenated pyridine derivatives from cycloaddition/cycloreversion of oxazinone and haloalkyne precursors. Tetrahedron Lett. 2025, 170, 155765. [Google Scholar] [CrossRef]
- Baumann, M.; Baxendale, I.R. An overview of the synthetic routes to the best selling drugs containing 6-membered heterocycles. Beilstein J. Org. Chem. 2013, 9, 2265–2310. [Google Scholar] [CrossRef] [PubMed]
- Bedekovic, N.; Magnabosco, A.; Stilinovic, V.; Cincic, D. Cocrystals of 1,2-diiodotetrafluorobenzene with pyridine derivatives: Pyridine nitrogen as a bifurcated acceptor with ortho-diiodo halogen bond donors. Cryst. Growth Des. 2026, 26, 554–564. [Google Scholar] [CrossRef] [PubMed]
- Topic, N.B.; Topic, E.; Fotovic, L.; Stilinovic, V. Isomorphism, polymorphism, and stoichiomorphism of cocrystals derived from 1,4-diiodotetrafluorobenzene and an isomorphous series of N-(4-halobenzyl)-3-halopyridinium halogenides. Cryst. Growth Des. 2024, 24, 1214–1226. [Google Scholar] [CrossRef]
- Rautiainen, J.M.; Green, M.; Mahonen, M.; Moilanen, J.O.; Lahtinen, M.; Valkonen, A. Halogen-bonded mono-, di-, and tritopic N-alkyl-3-iodopyridinium salts. Cryst. Growth Des. 2023, 23, 2361–2374. [Google Scholar] [CrossRef]
- Fotovic, L.; Bedekovic, N.; Piculjan, K.; Stilinovic, V. Order versus disorder in the cocrystals of m-halogenopyridines with m-halogenobenzoic acids: The effects of the I···O halogen bond. Cryst. Growth Des. 2022, 22, 7508–7517. [Google Scholar] [CrossRef]
- Culig, M.; Nemec, V.; Bregovic, N.; Cincic, D. Halopyridinium cations as bifunctional donors of halogen and hydrogen bonds in salts with benzenesulfonic and p-toluenesulfonic acids. CrystEngComm 2025, 27, 7638–7643. [Google Scholar] [CrossRef]
- Popa, M.M.; Man, I.C.; Draghici, C.; Shova, S.; Caira, M.R.; Dumitrascu, F.; Dumitrescu, D. Halogen bonding in 5-iodo-1-arylpyrazoles investigated in the solid state and predicted by solution 13C-NMR spectroscopy. CrystEngComm 2019, 21, 7085–7093. [Google Scholar] [CrossRef]
- Popa, M.M.; Shova, S.; Man, I.C.; Dumitrascu, F. Halogen bonding in 5-chloropyrazoles: Two new examples and a descriptive CSD investigation. J. Mol. Struct. 2025, 1319, 139384. [Google Scholar] [CrossRef]
- Dumitrescu, D.; Shova, S.; Draghici, C.; Popa, M.M.; Dumitrascu, F. Synthesis of 1-(2-Fluorophenyl)pyrazoles by 1,3-Dipolar Cycloaddition of the Corresponding Sydnones. Molecules 2021, 26, 3693. [Google Scholar] [CrossRef]
- Cristea, M.; Răducă, M.; Gdaniec, M.; Shova, S.; Banu, N.D.; Dumitrascu, F. Diethyl 3-(4-Bromobenzoyl)-7-(4-pyridyl)indolizine-1,2-dicarboxylate. Molbank 2025, 2025, M2032. [Google Scholar] [CrossRef]
- Saha, B.K.; Nangia, A.; Nicoud, J.-F. Using halogen···halogen interactions to direct noncentrosymmetric crystal packing in dipolar organic molecules. Cryst. Growth Des. 2006, 6, 1278–1281. [Google Scholar] [CrossRef]
- Hedidi, M.; Bentabed-Ababsa, G.; Derdour, A.; Halauko, Y.S.; Ivashkevich, O.A.; Matulis, V.E.; Chevallier, F.; Roisnel, T.; Dorcet, V.; Mangin, F. Deprotometalation of substituted pyridines and regioselectivity-computed CH acidity relationships. Tetraheron 2016, 72, 2196–2205. [Google Scholar] [CrossRef]
- Guo, W.; Liu, X.; Li, L.; Deng, D. 2-Iodo-3-methoxy-6-methylpyridine. Acta Cryst. E Cryst. Commun. 2009, 65, o3269. [Google Scholar] [CrossRef] [PubMed]
- Aycock, R.A.; Wang, H.; Jui, N.T. A mild catalytic system for radical conjugate addition of nitrogen heterocycles. Chem. Sci. 2017, 8, 3121–3125. [Google Scholar] [CrossRef] [PubMed]
- Thimmaraju, N.; Shamshuddin, S.Z.M.; Pratap, S.R.; Prasad, K.S. Effective synthesis of novel O-acetylated compounds over ZrO2-Al2O3 solid acid. Arab. J. Chem. 2019, 12, 1860–1869. [Google Scholar] [CrossRef]
- Draghici, C.; Caira, M.R.; Dumitrescu, D.E.; Dumitrascu, F. Halogen bonds of 4-iodosydnones in solution deduced from 13C-NMR spectra. Rev. Chim. 2018, 69, 843–845. [Google Scholar] [CrossRef]
- Gomila, R.M.; Frontera, A.; Bokach, N.A.; Kukushkin, V.Y. Halogens as noncovalent chemical chameleons: Electrophilic-nucleophilic dualism enabling multicenter halogen bond-based assemblies. Coord. Chem. Rev. 2026, 552, 217465. [Google Scholar] [CrossRef]
- Rigaku Oxford Diffraction. CrysAlisPro Software System, version 1.171.44.136a; Rigaku Corporation: Oxford, UK, 2015.
- Sheldrick, G.M. SHELXT—Integrated Space-Group and Crystal-Structure Determination. Acta Crystallogr. Sect. A Found. Crystallogr. 2015, 71, 3–8. [Google Scholar] [CrossRef]
- Sheldrick, G.M. Crystal Structure Refinement with SHELXL. Acta Crystallogr. Sect. C 2015, 71, 3–8. [Google Scholar] [CrossRef] [PubMed]
- Dolomanov, O.V.; Bourhis, L.J.; Gildea, R.J.; Howard, J.A.K.; Puschmann, H. OLEX2: A Complete Structure Solution, Refinement and Analysis Program. J. Appl. Crystallogr. 2009, 42, 339–341. [Google Scholar] [CrossRef]
- Spackman, P.R.; Turner, M.J.; McKinnon, J.J.; Wolff, S.K.; Grimwood, D.J.; Jayatilaka, D.; Spackman, M.A. CrystalExplorer: A program for Hirshfeld surface analysis, visualization and quantitative analysis of molecular crystals. J. Appl. Cryst. 2021, 54, 1006–1011. [Google Scholar] [CrossRef]









| D-X···A | D-X (Å) | D···A (Å) | X···A (Å) | DXA (◦) | Symmetry Op. |
|---|---|---|---|---|---|
| C1-I1···O2=C | 2.11 | N/A | 3.191(8) | 172.5(3) | 0.5 + x, 0.5 − y, 0.5 − z |
| C7-H7A···I1 | 0.97 | 4.077(10) | 3.18 | 155.2 | 1/2 + x, 1/2 − y, 1 − z |
| C7-H7B···O1 | 0.97 | 3.428(12) | 2.50 | 159.5 | 2 − x, −1/2 + y, 3/2 − z |
| C3-H3···O2 * | 0.93 | 3.467 | 2.79 | 130 | 1 − x, −1/2 + y, 3/2 − z |
| C7-H7C···N6 * | 0.97 | 3.397 | 2.79 | 121 | 3/2 − x, 1 − y, −1/2 + z |
| Empirical Formula | C7H6INO2 |
|---|---|
| Formula weight | 263.03 |
| Temperature/K | 240 |
| Space group | P212121 |
| a/Å | 7.3660(4) |
| b/Å | 8.0857(5) |
| c/Å | 14.5894(7) |
| α/° | 90 |
| β/° | 90 |
| γ/° | 90 |
| Volume/Å3 | 868.93(8) |
| Z | 4 |
| ρcalc g/cm3 | 2.011 |
| μ/mm−1 | 3.636 |
| Crystal size/mm3 | 0.06 × 0.06 × 0.02 |
| 2Θ range/° | 5.584 to 49.996 |
| Refs collected | 3032 |
| Indep. refls | 1505, 0.0387 |
| Data/restrs/params | 1505/0/101 |
| GOF on F2 | 0.999 |
| R1, wR2 (all data) | 0.0488, 0.0495 |
| CCDC No. | 2521105 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.
Share and Cite
Cristea, M.; Shova, S.; Popa, M.M.; Dumitrascu, F. 2-Iodopyridin-3-yl acetate. Molbank 2026, 2026, M2135. https://doi.org/10.3390/M2135
Cristea M, Shova S, Popa MM, Dumitrascu F. 2-Iodopyridin-3-yl acetate. Molbank. 2026; 2026(1):M2135. https://doi.org/10.3390/M2135
Chicago/Turabian StyleCristea, Mihaela, Sergiu Shova, Marcel Mirel Popa, and Florea Dumitrascu. 2026. "2-Iodopyridin-3-yl acetate" Molbank 2026, no. 1: M2135. https://doi.org/10.3390/M2135
APA StyleCristea, M., Shova, S., Popa, M. M., & Dumitrascu, F. (2026). 2-Iodopyridin-3-yl acetate. Molbank, 2026(1), M2135. https://doi.org/10.3390/M2135

